EFFICACY
Clinical trials for EFFICACY explained in plain language.
Never miss a new study
Get alerted when new EFFICACY trials appear
Sign up with your email to follow new studies for EFFICACY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could stem cells heal deadly skin wounds in kidney patients?
Disease control Recruiting nowThis study tests a new treatment using stem cells from amniotic membrane for people with calciphylaxis, a rare and painful condition where blood vessels harden and cause severe skin wounds. The treatment is given to 9 adults with chronic kidney disease to see if it helps wounds h…
Matched conditions: EFFICACY
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 17, 2026 06:28 UTC
-
New pill targets tough KRAS cancers in early trial
Disease control Recruiting nowThis study tests an experimental drug called HYP-2090PTSA in people with advanced solid tumors that have a specific genetic change called a KRAS mutation. The goal is to find the safest dose and see if the drug can shrink tumors. About 257 adults will take part in two phases: fir…
Matched conditions: EFFICACY
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New glasses aim to stop kids' eyesight from getting worse
Disease control Recruiting nowThis study tests two types of special glasses designed to slow the progression of nearsightedness (myopia) in children aged 6 to 14. Participants will wear the glasses daily for one year and attend regular eye exams. The goal is to see which lens design works best and whether the…
Matched conditions: EFFICACY
Phase: NA • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Stem cells injected into spine: hope for paralysis?
Disease control Recruiting nowThis early-stage study tests whether a single injection of special stem cells (made from reprogrammed human cells) is safe for people with a recent spinal cord injury. About 12 adults with moderate to severe paralysis will receive the cells. The main goal is to check for side eff…
Matched conditions: EFFICACY
Phase: PHASE1 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New drug HY07121 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called HY07121 in about 258 adults with advanced solid tumors that have not responded to standard treatments. The goal is to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants receive the drug by infusion, and t…
Matched conditions: EFFICACY
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 11, 2026 20:52 UTC